In vivo and in vitro efficacy of capecitabine (X) in combination with hormone therapies for breast cancer (BC)

被引：0
|
作者：
Mori, Kazushige
Yamaguchi, Yuri
Sawada, Noriaki
Kondoh, Kumiko
Hayashi, Shin-ichi
机构：
[1] Chugai Pharmaceut Co Ltd, Prod Res, Kamakura, Kanagawa, Japan
[2] Saitama Canc Ctr, Res Inst Clin Oncol, Ina, Saitama 362, Japan
[3] Tohoku Univ, Sch Med, Course Hlth Sci, Sendai, Miyagi 980, Japan
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [41] Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer
    Gursoy, Pinar
    Surmeli, Zeki Gokhan
    Cakar, Burcu
    Arslan, Cagatay
    Zengel, Baha
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells
    Ulivi, P.
    Arienti, C.
    Zoli, W.
    Scarsella, M.
    Carloni, S.
    Fabbri, F.
    Tesei, A.
    Chiadini, E.
    Orlandi, A.
    Passeri, D.
    Zupi, G.
    Milandri, C.
    Silvestrini, R.
    Amadori, D.
    Leonetti, C.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (06) : 600 - 610
  • [43] INTEGRATION OF CAPECITABINE (X) MONOTHERAPY WITH X COMBINATION THERAPY IN PATIENTS WITH METASTATIC BREAST CANCER (MBC): RATIONALE AND DESIGN OF X MAINTENANCE STUDY
    Wang, J.
    Xu, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 120 - 120
  • [44] Efficacy and safety of the combination of lapatinib plus capecitabine for HER2-positive advanced breast cancer.
    Aravantino-Fatorou, E.
    Christodoulou, C.
    Nikolakopoulou, A.
    Galani, E.
    Klouvas, G.
    Acholos, V.
    Karapanagiotidis, G.
    Batziou, E.
    Tsakalos, G.
    Skarlos, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer
    Sarici, Furkan
    Aksoy, Serean
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (02): : 85 - 91
  • [46] A pooled analysis of efficacy and safety of vinorelbine in combination with capecitabine in first-line metastatic breast cancer (MBC)
    Valev, Spartak S.
    Taushanova, Margarita
    Krasteva, Ely
    ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [47] Oral Combination Chemotherapy with Capecitabine and Cyclophosphamide Showed Good Efficacy and Quality of Life for Metastatic Breast Cancer Patient
    Kameshima, H.
    Ohmura, T.
    Kutomi, G.
    Shima, H.
    Takamaru, T.
    Satomi, F.
    Suzuki, Y.
    Hirata, K.
    Otokozawa, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S116 - S117
  • [48] Efficacy of low-dose capecitabine in metastatic breast cancer
    Bertelsen, Caitlin
    Ji, Lingyun
    Russell, Christy Ann
    Spicer, Darcy V.
    Garcia, Agustin
    Sposto, Richard
    Tripathy, Debu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
    Wang, Congcong
    Xiang, Jinyu
    Zhang, Qingyu
    Li, Jing
    Liu, Yanqing
    Liu, Jiannan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 909 - 917
  • [50] Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer
    Feng, Mengya
    Bi, Pingping
    Kang, Yihua
    Yang, Dechun
    Ren, Shengnan
    Lu, Xianping
    Xie, Guojian
    Lei, Hai
    Mo, Dan
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
12345